NO20005621D0 - Nye medikamentkombinasjoner - Google Patents
Nye medikamentkombinasjonerInfo
- Publication number
- NO20005621D0 NO20005621D0 NO20005621A NO20005621A NO20005621D0 NO 20005621 D0 NO20005621 D0 NO 20005621D0 NO 20005621 A NO20005621 A NO 20005621A NO 20005621 A NO20005621 A NO 20005621A NO 20005621 D0 NO20005621 D0 NO 20005621D0
- Authority
- NO
- Norway
- Prior art keywords
- disorders
- new drug
- drug combinations
- anxiety
- nari
- Prior art date
Links
- 239000002547 new drug Substances 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 2
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 2
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 2
- 208000019906 panic disease Diseases 0.000 abstract 2
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 206010041250 Social phobia Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 238000011284 combination treatment Methods 0.000 abstract 1
- PHUTUTUABXHXLW-UHFFFAOYSA-N pindolol Chemical compound CC(C)NCC(O)COC1=CC=CC2=NC=C[C]12 PHUTUTUABXHXLW-UHFFFAOYSA-N 0.000 abstract 1
- 229960002508 pindolol Drugs 0.000 abstract 1
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical compound CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 abstract 1
- 229960003770 reboxetine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8486098P | 1998-05-08 | 1998-05-08 | |
| PCT/US1999/006523 WO1999058130A1 (en) | 1998-05-08 | 1999-04-14 | New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005621L NO20005621L (no) | 2000-11-07 |
| NO20005621D0 true NO20005621D0 (no) | 2000-11-07 |
Family
ID=22187677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005621A NO20005621D0 (no) | 1998-05-08 | 2000-11-07 | Nye medikamentkombinasjoner |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP1075264B1 (es) |
| JP (1) | JP2002514601A (es) |
| KR (1) | KR20010052319A (es) |
| CN (1) | CN1300217A (es) |
| AT (1) | ATE283694T1 (es) |
| AU (1) | AU764579B2 (es) |
| BR (1) | BR9909559A (es) |
| CA (1) | CA2326105A1 (es) |
| DE (1) | DE69922367T2 (es) |
| EA (1) | EA003469B1 (es) |
| ES (1) | ES2232128T3 (es) |
| HU (1) | HUP0101341A3 (es) |
| IL (1) | IL139211A0 (es) |
| NO (1) | NO20005621D0 (es) |
| NZ (1) | NZ508035A (es) |
| PL (1) | PL345351A1 (es) |
| PT (1) | PT1075264E (es) |
| SI (1) | SI1075264T1 (es) |
| SK (1) | SK14502000A3 (es) |
| TR (1) | TR200003262T2 (es) |
| WO (1) | WO1999058130A1 (es) |
| ZA (1) | ZA200005301B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60022692T2 (de) | 1999-07-01 | 2006-06-22 | Pharmacia & Upjohn Co. Llc, Kalamazoo | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen |
| EP1632235A3 (en) * | 1999-07-01 | 2006-06-14 | Pharmacia & Upjohn Company LLC | Use of highly selective norepinephrine reuptake inhibitors for the treatment of mental disorders |
| US20040102440A1 (en) * | 2002-07-01 | 2004-05-27 | Wong Erik Ho Fong | Method of promoting smoking cessation |
| CA2529857A1 (en) | 2002-07-30 | 2004-02-05 | Peter Migaly | Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions |
| KR100842694B1 (ko) | 2002-12-27 | 2008-07-01 | 오쓰까 세이야꾸 가부시키가이샤 | 기분 장애 치료용 카르보스티릴 유도체 및 세로토닌 재흡수억제제 |
| AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
| JP2012526832A (ja) * | 2009-05-13 | 2012-11-01 | スノビオン プハルマセウトイカルス インコーポレイテッド | トランスノルセルトラリン及びセロトニン受容体１ａ作動剤／拮抗剤を含む組成物及びその使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| DK0759299T3 (da) * | 1995-08-16 | 2000-08-07 | Lilly Co Eli | Potensering af serotoninrespons |
-
1999
- 1999-04-14 SK SK1450-2000A patent/SK14502000A3/sk unknown
- 1999-04-14 AT AT99917309T patent/ATE283694T1/de not_active IP Right Cessation
- 1999-04-14 PT PT99917309T patent/PT1075264E/pt unknown
- 1999-04-14 CA CA002326105A patent/CA2326105A1/en not_active Abandoned
- 1999-04-14 EP EP99917309A patent/EP1075264B1/en not_active Expired - Lifetime
- 1999-04-14 AU AU35460/99A patent/AU764579B2/en not_active Ceased
- 1999-04-14 TR TR2000/03262T patent/TR200003262T2/xx unknown
- 1999-04-14 IL IL13921199A patent/IL139211A0/xx not_active IP Right Cessation
- 1999-04-14 CN CN99805216A patent/CN1300217A/zh active Pending
- 1999-04-14 EA EA200001162A patent/EA003469B1/ru not_active IP Right Cessation
- 1999-04-14 DE DE69922367T patent/DE69922367T2/de not_active Expired - Fee Related
- 1999-04-14 SI SI9930716T patent/SI1075264T1/xx unknown
- 1999-04-14 JP JP2000547981A patent/JP2002514601A/ja not_active Withdrawn
- 1999-04-14 BR BR9909559-9A patent/BR9909559A/pt not_active Application Discontinuation
- 1999-04-14 KR KR1020007012418A patent/KR20010052319A/ko not_active Ceased
- 1999-04-14 HU HU0101341A patent/HUP0101341A3/hu unknown
- 1999-04-14 ES ES99917309T patent/ES2232128T3/es not_active Expired - Lifetime
- 1999-04-14 PL PL99345351A patent/PL345351A1/xx not_active Application Discontinuation
- 1999-04-14 NZ NZ508035A patent/NZ508035A/xx unknown
- 1999-04-14 WO PCT/US1999/006523 patent/WO1999058130A1/en not_active Ceased
-
2000
- 2000-09-29 ZA ZA200005301A patent/ZA200005301B/en unknown
- 2000-11-07 NO NO20005621A patent/NO20005621D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010052319A (ko) | 2001-06-25 |
| SK14502000A3 (sk) | 2001-05-10 |
| AU3546099A (en) | 1999-11-29 |
| NZ508035A (en) | 2004-02-27 |
| CN1300217A (zh) | 2001-06-20 |
| ATE283694T1 (de) | 2004-12-15 |
| PT1075264E (pt) | 2005-01-31 |
| WO1999058130A1 (en) | 1999-11-18 |
| DE69922367D1 (de) | 2005-01-05 |
| EP1075264A1 (en) | 2001-02-14 |
| NO20005621L (no) | 2000-11-07 |
| BR9909559A (pt) | 2000-12-19 |
| AU764579B2 (en) | 2003-08-21 |
| ES2232128T3 (es) | 2005-05-16 |
| TR200003262T2 (tr) | 2001-03-21 |
| HUP0101341A2 (hu) | 2001-08-28 |
| PL345351A1 (en) | 2001-12-17 |
| JP2002514601A (ja) | 2002-05-21 |
| EA003469B1 (ru) | 2003-06-26 |
| DE69922367T2 (de) | 2005-12-22 |
| ZA200005301B (en) | 2001-10-01 |
| EA200001162A1 (ru) | 2001-04-23 |
| HUP0101341A3 (en) | 2006-07-28 |
| IL139211A0 (en) | 2001-11-25 |
| SI1075264T1 (en) | 2005-06-30 |
| EP1075264B1 (en) | 2004-12-01 |
| CA2326105A1 (en) | 1999-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124111T1 (el) | Παραγοντες ρυθμισης γλουταμικου στην αντιμετωπιση ψυχικων διαταραχων | |
| CY1107924T1 (el) | Παραγωγα φαινυλ-πιπεραζινης ως αναστολεις επαναπροσληψης σεροτονινης | |
| NO20064277L (no) | 6-substituerte 2,3,4,5-tetrahydro-1H-benzo[d]azepiner som 5-HT2C reseptoragonister | |
| DE60233655D1 (de) | R und retinoid x rezeptorenmodulatoren | |
| CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
| NO20053185D0 (no) | Behandling av oppmerksomhetssviktshyperaktivitetsforstyrrelse. | |
| NO20005621D0 (no) | Nye medikamentkombinasjoner | |
| ATE422498T1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
| NO20070914L (no) | Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander | |
| DK1626720T3 (da) | 4-(2-Phenylsulfanyl-phenyl)-piperidinderivater som serotonin-genoptagelseshæmmer | |
| ATE424825T1 (de) | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten | |
| ATE457309T1 (de) | Modulatoren von peripheren 5-ht-rezeptoren | |
| MY136367A (en) | Treatment of cognitive failure | |
| WO2002040006A3 (en) | Treatment of anxiety disorders | |
| NO20055206L (no) | 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer | |
| BRPI0511529A (pt) | combinação terapêutica para distúrbios de hiperatividade/déficit de atenção | |
| DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
| DK1071418T3 (da) | Nye behandlinger til nervelidelser | |
| EA200870533A1 (ru) | Производные 3-(1н-индол-3-ил)индан-1-иламина для лечения депрессии и тревожности | |
| NO20061425L (no) | Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin | |
| ATE291920T1 (de) | Verwendung von quetiapin für aufmerksamkeitsmangel-hyperaktivitätsstörungen oder verhaltensstörungen | |
| DE60215219D1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| ATE423772T1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
| NO20062700L (no) | Morfolinderivater som norepinefrin reopptaksinhibitorer | |
| PT1282414E (pt) | Compostos derivados de felbamato para o tratamento da dor neuropatica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |